HomeQuestion

In light of RxPonder results for postmenopausal women with early stage node positive HR+HER2- breast cancer, when is there a role for full axillary LN dissection to confirm degree of nodal involvement and when would sentinel LN evaluation be sufficient?

1 Answers

Mednet Member

Medical Oncology · Northwestern Medicine Cancer Center at KishHealth

I don’t think the RxPonder study changes surgical management. Still follow Z0011 paradigm.

In light of RxPonder results for postmenopausal women with early stage node positive HR+HER2- breast cancer, when is there a role for full axillary LN dissection to confirm degree of nodal involvement and when would sentinel LN evaluation be sufficient? | Mednet